News & Events

Nine gene and cell therapy projects across the Westmead Health Precinct (Sydney Children’s Hospitals Network, Children’s Medical Research Institute (CMRI), The Westmead Institute for Medical Research (WIMR)) have been awarded funding to offer PhD scholarships for graduates to undertake research within the gene and gene-modified somatic cell therapy development and manufacture sectors by the NSW G...

Register now for the first of a series of webinars that explores the way Advanced Therapeutics is driving clinicians and researchers to prepare for a new wave of therapies - revolutionising the future of paediatric health care. We are in a new era of paediatric medicine. Therapy that targets the underlying genetic defect causing disease is now available for a small but increasing number of dis...

The global outbreak of COVID-19 has impacted all children and young people in Australia. A study led by joint departments at Sydney Children’s Hospitals Network recently published in the Journal of Paediatrics and Child Health, highlighted the impact the pandemic is having on vulnerable groups of children and young people, particularly those who already experience poor health and well-being....

A phase III multicentre clinical trial conducted in seven countries (Australia, Germany, Japan, Spain, Turkey, USA and UK) has successfully shown that a new drug boosts bone growth in children born with achondroplasia. The study has been recently published in The Lancet and was led by Murdoch Children’s Research Institute along with investigators, Dr Louise Tofts, Paediatric Rehabilitatio...